1. National Institutes of Health: Better data will improve understanding of federal contributions to drug development : report to congressional requesters Publication: Washington, DC : United States Government Accountability Office, April 2023 Subject(s): Biomedical Research -- economicsDrug Development -- economicsFinancing, Government -- organization & administrationGovernment RegulationHealth Occupations -- educationLegislation, DrugUnited StatesNational Institutes of Health (U.S.)
